Venous thromboembolism therapy with rivaroxaban in daily-care patients: results from the Dresden NOAC registry

L Keller, S Marten, J Hecker, K Sahin, L Tittl… - International Journal of …, 2018 - Elsevier
The effectiveness and safety of acute venous thromboembolism (VTE) treatment with
rivaroxaban, demonstrated in phase-III trials, needs to be confirmed in daily care. To confirm …
被引用次数：30 相关文章

Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry

L Keller, S Marten, J Hecker… - International …, 2018 - internationaljournalofcardiology.com
The effectiveness and safety of acute venous thromboembolism (VTE) treatment with
rivaroxaban, demonstrated in phase-III trials, needs to be confirmed in daily care. To confirm …

Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry.

L Keller, S Marten, J Hecker, K Sahin, L Tittl… - … Journal of Cardiology, 2018 - europepmc.org
The effectiveness and safety of acute venous thromboembolism (VTE) treatment with
rivaroxaban, demonstrated in phase-III trials, needs to be confirmed in daily care. To confirm …

[引用][C] Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry

L Keller, S Marten, J Hecker, K Sahin, L Tittl… - International Journal of …, 2018 - cir.nii.ac.jp
Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the
Dresden NOAC registry | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry

L Keller, S Marten, J Hecker, K Sahin… - International …, 2018 - pubmed.ncbi.nlm.nih.gov
The effectiveness and safety of acute venous thromboembolism (VTE) treatment with
rivaroxaban, demonstrated in phase-III trials, needs to be confirmed in daily care. To confirm …